Peptides targeting the hallmarks of aging — mitochondrial function, DNA repair, and cellular energy.
NAD+ replenishes a coenzyme central to cellular energy and DNA repair that declines steeply with age, while MOTS-c, a mitochondria-derived peptide, regulates metabolic flexibility and insulin sensitivity. Epithalon rounds out the category with telomere-supporting research.

Long-acting amylin analogue that enhances satiety; often paired with semaglutide (CagriSema) for additive fat loss.
Evidence Level

Neuropeptide preparation studied for neuroprotection, stroke recovery, and cognitive enhancement.
Evidence Level

Extended GHRH analogue — the perfect stack partner for Ipamorelin.
Evidence Level

Telomerase-activating tetrapeptide considered one of the most promising longevity peptides.
Evidence Level

The most researched copper peptide for skin rejuvenation and hair growth.
Evidence Level

Growth-hormone-releasing peptide that boosts GH and appetite; commonly stacked with a GHRH like CJC-1295.
Evidence Level

Mitochondrial-derived peptide studied for cytoprotection, metabolic health, and longevity signaling.
Evidence Level

The beginner-friendly GHRP for sleep quality, recovery, and anti-aging.
Evidence Level

Orally active ghrelin-receptor agonist that raises GH and IGF-1 around the clock — no injection required.
Evidence Level

Mitochondrial-derived peptide that improves insulin sensitivity, metabolic flexibility, and exercise capacity.
Evidence Level

Essential cellular coenzyme used to support energy metabolism, DNA repair, and healthy aging.
Evidence Level

Next-generation triple agonist (GLP-1 / GIP / glucagon) producing the largest weight-loss results seen in trials to date.
Evidence Level

The widely studied GLP-1 agonist behind modern weight-loss medicine — strong appetite control and metabolic benefits.
Evidence Level

Classic GHRH peptide that gently stimulates the body's own growth-hormone release for sleep, recovery, and anti-aging.
Evidence Level

Mitochondria-targeting peptide researched for cellular energy, cardiac function, and age-related decline.
Evidence Level

GLP-1 / glucagon dual agonist studied for weight loss and metabolic-associated fatty liver disease (MASH).
Evidence Level

GHRH analogue clinically proven to reduce visceral (deep belly) fat and improve body composition.
Evidence Level

Immune-modulating peptide that helps regulate T-cell function and resilience to infection.
Evidence Level

Dual GLP-1 / GIP agonist for powerful appetite suppression, blood-sugar control, and fat loss.
Evidence Level
Cycling schedules, IV vs subcutaneous guidance, and stacking protocols are available with a subscription.
Start Free Trial7 days free. Then $24/month.
PepCompass provides educational information only. Nothing on this platform constitutes medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.